$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

$lbuy Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000147793224006885 Filed on November 05, 2024

Income Statement

Concept	2024 Q4	2024 Q2	2024
Revenue		$1.501M	$5.601M
YoY Change		12.85%	10.03%
Cost Of Revenue		$816.9K	$3.549M
YoY Change		4.73%	24.85%
Gross Profit		$684.0K	$2.052M
YoY Change		26.67%	-8.72%
Gross Profit Margin		45.57%	36.63%
Selling, General & Admin		$573.0K	$2.639M
YoY Change		-64.63%	-1.11%
% of Gross Profit		83.77%	128.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$79.03K	$622.4K
YoY Change		-56.09%	-13.56%
% of Gross Profit		11.55%	30.33%
Operating Expenses		$573.0K	$2.639M
YoY Change		-15.73%	-1.11%
Operating Profit		$111.0K	-$586.5K
YoY Change		-179.29%	39.57%
Interest Expense		-$30.18K	$123.0K
YoY Change		-24.55%	-172.33%
% of Operating Profit		-27.19%
Other Income/Expense, Net		$0.00	-$1.229M
YoY Change
Pretax Income		$80.83K	-$709.4K
YoY Change		-147.55%	20.24%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		$80.83K	-$709.4K
YoY Change		-147.55%	21.23%
Net Earnings / Revenue		5.39%	-12.67%
Basic Earnings Per Share			$0.00
Diluted Earnings Per Share		$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	100.1M shares		99.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$165.3K	$165.3K
YoY Change	-63.26%	-63.26%
Cash & Equivalents	$165.3K	$165.3K
Short-Term Investments
Other Short-Term Assets	$21.21K	$21.21K
YoY Change	-29.3%	-29.3%
Inventory
Prepaid Expenses
Receivables	$83.48K	$83.48K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$270.0K	$270.0K
YoY Change	-55.77%	-55.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.000K	$1.000K
YoY Change
Total Long-Term Assets	$603.7K	$603.7K
YoY Change	-50.72%	-50.92%
TOTAL ASSETS
Total Short-Term Assets	$270.0K	$270.0K
Total Long-Term Assets	$603.7K	$603.7K
Total Assets	$873.7K	$873.7K
YoY Change	-52.4%	-52.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$129.4K	$129.4K
YoY Change	-58.11%	-58.27%
Accrued Expenses	$934.3K	$934.3K
YoY Change	-19.86%	-20.15%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.061M	$1.061M
YoY Change	-6.91%	-6.91%
Total Short-Term Liabilities	$2.136M	$2.136M
YoY Change	-18.75%	-18.78%
LONG-TERM LIABILITIES
Long-Term Debt	$419.2K	$419.2K
YoY Change	-13.64%	-14.45%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$419.2K	$419.2K
YoY Change	-13.64%	-14.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.136M	$2.136M
Total Long-Term Liabilities	$419.2K	$419.2K
Total Liabilities	$2.555M	$2.555M
YoY Change	-17.95%	-17.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.15M
YoY Change	2.9%
Common Stock	$100.1K
YoY Change	0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.682M	-$1.682M
YoY Change
Total Liabilities & Shareholders Equity	$873.7K	$873.7K
YoY Change	-52.4%	-52.52%

Cashflow Statement

Concept	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	$80.83K	-$709.4K
YoY Change	-147.55%	21.23%
Depreciation, Depletion And Amortization	$79.03K	$622.4K
YoY Change	-56.09%	-13.56%
Cash From Operating Activities	$51.71K	-$131.1K
YoY Change	-42.54%	-131.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-42.31K	-$149.2K
YoY Change	-47.11%
NET CHANGE
Cash From Operating Activities	51.71K	-$131.1K
Cash From Investing Activities
Cash From Financing Activities	-42.31K	-$149.2K
Net Change In Cash	9.400K	-$280.4K
YoY Change	-6.0%	-457.28%
FREE CASH FLOW
Cash From Operating Activities	$51.71K	-$131.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165332	usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001643721
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2024	dei	Trading Symbol TradingSymbol	LBUY
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99428575	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100071075	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7568	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7568	shares
CY2023Q2	lbuy	Preferred Stock Shares Designated PreferredStockSharesDesignated	27027	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	333-206745
CY2024	dei	Entity Registrant Name EntityRegistrantName	LEAFBUYER TECHNOLOGIES, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3944821
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	6888 S. Clinton Street
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 301
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
CY2024	dei	City Area Code CityAreaCode	720
CY2024	dei	Local Phone Number LocalPhoneNumber	235-0099
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	3977143	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	100071075	shares
CY2024	dei	Auditor Name AuditorName	BCRG Group
CY2024	dei	Auditor Firm AuditorFirmId	7158
CY2024	dei	Auditor Location AuditorLocation	Irvine, CA
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	165332	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445712	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	90151	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	83480	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135476	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21208	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28277	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	270020	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	609465	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	602674	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1225034	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	1000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	1000	usd
CY2024Q2	us-gaap	Assets Assets	873694	usd
CY2023Q2	us-gaap	Assets Assets	1835499	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	129367	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	308840	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	934279	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1165815	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	11140	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10029	usd
CY2024Q2	lbuy	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	137817	usd
CY2023Q2	lbuy	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	107817	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	429000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	500000	usd
CY2024Q2	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	29640	usd
CY2023Q2	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	29244	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	464802	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	543802	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2136045	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2665547	usd
CY2024Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	419183	usd
CY2023Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	448823	usd
CY2024Q2	us-gaap	Liabilities Liabilities	2555228	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3114370	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	lbuy	Preferred Stock Shares Designated PreferredStockSharesDesignated	27027	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7568	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7568	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	8	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	8	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100071075	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99428575	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	100070	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	99428	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23363192	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23057067	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25145128	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24435698	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1681534	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1278871	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	873694	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1835499	usd
CY2024	us-gaap	Revenues Revenues	5601357	usd
CY2023	us-gaap	Revenues Revenues	5090846	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	3549328	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	2842786	usd
CY2024	us-gaap	Gross Profit GrossProfit	2052029	usd
CY2023	us-gaap	Gross Profit GrossProfit	2248060	usd
CY2024	us-gaap	Selling Expense SellingExpense	816180	usd
CY2023	us-gaap	Selling Expense SellingExpense	717270	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1822365	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1951013	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	2638545	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2668283	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-586516	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-420223	usd
CY2024	us-gaap	Interest Expense InterestExpense	122963	usd
CY2023	us-gaap	Interest Expense InterestExpense	168440	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	49	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3452	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1229143	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-164988	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-709430	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-585211	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99716697	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95923444	shares
CY2024	us-gaap	Profit Loss ProfitLoss	-709430	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-585211	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	280665	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	360105	usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	26102	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	102782	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	622358	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	724445	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-51996	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	106391	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7069	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6159	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-179471	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-52096	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-231536	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-12215	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1111	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2668	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-131136	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	422592	usd
CY2024	lbuy	Proceeds From Notes Payable To Related Parties ProceedsFromNotesPayableToRelatedParties	30000	usd
CY2023	lbuy	Proceeds From Notes Payable To Related Parties ProceedsFromNotesPayableToRelatedParties	-217183	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	71000	usd
CY2024	lbuy	Repayments On Note Payable To Bank Under Eidl Loan RepaymentsOnNotePayableToBankUnderEidlLoan	29244	usd
CY2023	lbuy	Repayments On Note Payable To Bank Under Eidl Loan RepaymentsOnNotePayableToBankUnderEidlLoan	21933	usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	79000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	105000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-149244	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-344116	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-280380	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	78476	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445712	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367246	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	165332	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445712	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1412547	usd
CY2023	lbuy	Stock Based Compensation For Employees StockBasedCompensationForEmployees	360105	usd
CY2023	lbuy	Issuance Of Common Stock For Employee Compensation Amount IssuanceOfCommonStockForEmployeeCompensationAmount	30420	usd
CY2023	lbuy	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	72362	usd
CY2023	lbuy	Issuance Of Common Stock To Reduce Debt Amount IssuanceOfCommonStockToReduceDebtAmount	256000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-585211	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1278871	usd
CY2024	lbuy	Stock Based Compensation For Employees StockBasedCompensationForEmployees	280665	usd
CY2024	lbuy	Issuance Of Common Stock For Employee Compensation Amount IssuanceOfCommonStockForEmployeeCompensationAmount	23062	usd
CY2024	lbuy	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	3040	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-709430	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1681534	usd
CY2024Q2	lbuy	Working Capital Deficit WorkingCapitalDeficit	-1836385	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25145128	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-709430	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management uses estimates and assumptions in preparing these consolidated financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Examples of estimates include loss contingencies; useful lives of our fixed assets and intangible assets; allowances for doubtful accounts; and stock-based compensation forfeiture rates. Examples of assumptions include: the elements comprising a software arrangement, including the distinction between upgrades or enhancements and new products; when technological feasibility is achieved for our products; the potential outcome of future tax consequences of events that have been recognized in our financial statements or tax returns. Actual results could differ from those estimates.</p>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	90151	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2024	lbuy	Fixed Assets And Intangible Assets Depreciation Desription FixedAssetsAndIntangibleAssetsDepreciationDesription	acquisition and implementation and enhancement costs during the first 2 year and are depreciated on a straight-line basis over their estimated useful lives of five to seven years
CY2024	us-gaap	Intangible Assets Finite Lived Policy Costs Incurred To Renew Or Extend IntangibleAssetsFiniteLivedPolicyCostsIncurredToRenewOrExtend	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other” includes software that is part of a product or process to be sold to a customer and shall be accounted for under Subtopic 985-20. Our products contain embedded software internally developed by FTI, which is an integral part of these products because it allows the various components of the products to communicate with each other and the products are clearly unable to function without this coding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The costs of product development that are capitalized once technological feasibility is determined (noted as Technology in progress in the Intangible Assets table, in Note 2 to Notes to Consolidated Financial Statements) include certifications, licenses, payroll, employee benefits, and other headcount-related expenses associated with product development. We determine that technological feasibility for our products is reached after all high-risk development issues have been resolved. Once the products are available for general release to our customers, we cease capitalizing the product development costs and any additional costs, if any, are expensed. The capitalized product development costs are amortized on a product-by-product basis using the straight-line amortization. The amortization begins when the products are available for general release to our customers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of June 30, 2024, and 2023, capitalized product development costs in progress were $0 and $203,838, respectively, and these amounts are included in intangible assets in our consolidated balance sheets. For the years ended June 30, 2024 and 2023, we incurred $123,359 and $1,631,376, respectively in capitalized product development costs, and all costs incurred before technological feasibility is reached are expensed and included in our consolidated statements of comprehensive income (loss).</p>
CY2024Q2	lbuy	Capitalized Software Development Costs CapitalizedSoftwareDevelopmentCosts	0	usd
CY2023Q2	lbuy	Capitalized Software Development Costs CapitalizedSoftwareDevelopmentCosts	203838	usd
CY2024	us-gaap	Costs Incurred Oil And Gas Property Acquisition Exploration And Development Activities CostsIncurredOilAndGasPropertyAcquisitionExplorationAndDevelopmentActivities	123359	usd
CY2023	us-gaap	Costs Incurred Oil And Gas Property Acquisition Exploration And Development Activities CostsIncurredOilAndGasPropertyAcquisitionExplorationAndDevelopmentActivities	1631376	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	10029	usd
CY2024	lbuy	Deferred Revenue Earned DeferredRevenueEarned	11460	usd
CY2024	lbuy	Customer Payments Received CustomerPaymentsReceived	12571	usd
CY2024Q2	us-gaap	Deferred Revenue DeferredRevenue	11140	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4482225	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4482225	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3879551	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3257191	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	602674	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1225034	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	622358	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	724445	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	459342	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	143332	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	602674	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	lbuy	Articles Of Amendment ArticlesOfAmendment	the Company filed Articles of Amendment to Amended and Restated Articles of Incorporation with the State of Nevada increasing the number of common shares from 150,000,000 to 700,000,000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	lbuy	Related Party Transaction Amounts Of Transaction Notes Payable Gross RelatedPartyTransactionAmountsOfTransactionNotesPayableGross	137817	usd
CY2023Q2	lbuy	Related Party Transaction Amounts Of Transaction Notes Payable Gross RelatedPartyTransactionAmountsOfTransactionNotesPayableGross	107817	usd
CY2024Q2	lbuy	Related Party Transaction Amounts Of Transaction Current Portion Of Notes Payable RelatedPartyTransactionAmountsOfTransactionCurrentPortionOfNotesPayable	-137817	usd
CY2023Q2	lbuy	Related Party Transaction Amounts Of Transaction Current Portion Of Notes Payable RelatedPartyTransactionAmountsOfTransactionCurrentPortionOfNotesPayable	-107817	usd
CY2024Q2	lbuy	Related Party Transaction Amounts Of Transaction Notes Payable RelatedPartyTransactionAmountsOfTransactionNotesPayable	0	usd
CY2023Q2	lbuy	Related Party Transaction Amounts Of Transaction Notes Payable RelatedPartyTransactionAmountsOfTransactionNotesPayable	0	usd
CY2024	lbuy	Related Party Transaction Amounts Of Transaction Interest Expense RelatedPartyTransactionAmountsOfTransactionInterestExpense	20480	usd
CY2023	lbuy	Related Party Transaction Amounts Of Transaction Interest Expense RelatedPartyTransactionAmountsOfTransactionInterestExpense	50543	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	429000	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	500000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	429000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	500000	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2024	us-gaap	Interest Expense Other InterestExpenseOther	18000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	26751	usd
CY2024Q2	lbuy	Notes Payable To Bank Current Eidl Loan NotesPayableToBankCurrentEIDLLoan	0	usd
CY2023Q2	lbuy	Notes Payable To Bank Current Eidl Loan NotesPayableToBankCurrentEIDLLoan	0	usd
CY2024Q2	lbuy	Notes Payable To Bank Noncurrent Eidl Loan NotesPayableToBankNoncurrentEIDLLoan	448823	usd
CY2023Q2	lbuy	Notes Payable To Bank Noncurrent Eidl Loan NotesPayableToBankNoncurrentEIDLLoan	478067	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	464802	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	543802	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	464802	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	543802	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	usd
CY2024	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	63186	usd
CY2023	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	57341	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	10728983	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	10728983	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2306450	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2306450	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13035433	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13035433	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13035433	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13035433	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.14
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.07
CY2024	lbuy	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Minimum SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1Minimum	P2Y
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2023	lbuy	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Minimum SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1Minimum	P2Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	2.27	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.54	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	2.27	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.54	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0044	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0054	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0044	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0054	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	13450170	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2500000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.04
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	15287562	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.07
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	662608	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	662608	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.11
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.00
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29119898	shares
CY2023Q2	lbuy	Aggregate Intrinsic Value AggregateIntrinsicValue	0	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28432941	shares
CY2024Q2	lbuy	Aggregate Intrinsic Value AggregateIntrinsicValue	0	usd
CY2024	lbuy	Related Party Transaction Amounts Of Transaction Interest Expense RelatedPartyTransactionAmountsOfTransactionInterestExpense	20480	usd
CY2023	lbuy	Related Party Transaction Amounts Of Transaction Interest Expense RelatedPartyTransactionAmountsOfTransactionInterestExpense	50543	usd
CY2024	lbuy	Lessee Operating Lease Term Period LesseeOperatingLeaseTermPeriod	P12M
CY2024	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The Company will recognize lease expense on a monthly basis through the life of this lease
CY2024	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	41000	usd

Files In Submission

Name	View Source	Status
0001477932-24-006885-index-headers.html	Edgar Link	pending
0001477932-24-006885-index.html	Edgar Link	pending
0001477932-24-006885.txt	Edgar Link	pending
0001477932-24-006885-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lbuy-20240630.xsd	Edgar Link	pending
lbuy_10k.htm	Edgar Link	pending
lbuy_ex311.htm	Edgar Link	pending
lbuy_ex312.htm	Edgar Link	pending
lbuy_ex321.htm	Edgar Link	pending
lbuy_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
lbuy_10k_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lbuy-20240630_def.xml	Edgar Link	unprocessable
lbuy-20240630_cal.xml	Edgar Link	unprocessable
lbuy-20240630_lab.xml	Edgar Link	unprocessable
lbuy-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

2024 Q4 Form 10-K Financial Statement

#000147793224006885 Filed on November 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

2024 Q4 Form 10-K Financial Statement

#000147793224006885 Filed on November 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy